Pulsenmore (PLSM) Current Deferred Revenue (2025)
Pulsenmore (PLSM) posted Current Deferred Revenue of $294000.0 for Q4 2025.
Pulsenmore (PLSM) Current Deferred Revenue (2025) Analysis & Trends
Pulsenmore has reported Current Deferred Revenue for 1 years, with the latest figure at $294000.0 in Q4 2025.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $294000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $294000.0 (changed N/A YoY) and the FY2025 annual result came in at $294000.0, changed N/A from the prior year.
- Current Deferred Revenue was little changed at $294000.0 in Q4 2025 per PLSM's latest filing.
- Over five years, Current Deferred Revenue peaked at $294000.0 in Q4 2025 and troughed at $294000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Pulsenmore | 18.62 Mn | -3.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 294,000.00 |